PDB Short entry for 3MOW HEADER HYDROLASE/HYDROLASE INHIBITOR 23-APR-10 3MOW TITLE CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A TAUTOMYCETIN ANALOG TTN D- TITLE 2 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (UNP RESIDUES 262-528); COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 2C, PTP-2C, PROTEIN-TYROSINE COMPND 6 PHOSPHATASE 1D, PTP-1D, SH-PTP3, SH-PTP2, SHP-2, SHP2; COMPND 7 EC: 3.1.3.48; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTP2C, PTPN11, SHPTP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21A KEYWDS NATURAL PRODUCT, CATALYTIC DOMAIN, INHIBITOR, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.-Y.ZHANG,S.LIU,Z.YU,X.YU REVDAT 2 06-SEP-23 3MOW 1 COMPND REMARK SEQADV HETNAM REVDAT 1 04-MAY-11 3MOW 0 JRNL AUTH Z.-Y.ZHANG,S.LIU,Z.YU,X.YU,S.-X.HUANG,Y.LUO,L.WU,Z.YANG, JRNL AUTH 2 L.WANG,A.M.GUNAWAN,R.J.CHAN,B.SHEN JRNL TITL CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A TAUTOMYCETIN JRNL TITL 2 ANALOG TTN D-1 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.500 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.8 REMARK 3 NUMBER OF REFLECTIONS : 11704 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 483 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.190 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : B2B_PAR.TXT REMARK 3 PARAMETER FILE 4 : WATER.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : B2B_TOP.TXT REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3MOW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000058815. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12544 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.27400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3JRL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% W/V POLYETHYLENE GLYCOL 3350, 100 REMARK 280 MM SODIUM CHLORIDE, AND 100 MM HEPES BUFFER (PH 7.5), VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.98850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 261 REMARK 465 PHE A 314 REMARK 465 GLU A 315 REMARK 465 THR A 316 REMARK 465 LYS A 317 REMARK 465 CYS A 318 REMARK 465 ASN A 319 REMARK 465 ASN A 320 REMARK 465 SER A 321 REMARK 465 LYS A 322 REMARK 465 PRO A 323 REMARK 465 LYS A 324 REMARK 465 ARG A 527 REMARK 465 ARG A 528 REMARK 465 LEU A 529 REMARK 465 GLU A 530 REMARK 465 HIS A 531 REMARK 465 HIS A 532 REMARK 465 HIS A 533 REMARK 465 HIS A 534 REMARK 465 HIS A 535 REMARK 465 HIS A 536 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 459 -157.60 -132.49 REMARK 500 ILE A 463 -45.52 -131.69 REMARK 500 LYS A 482 -145.77 -89.59 REMARK 500 VAL A 484 14.88 -64.27 REMARK 500 ARG A 501 111.29 -171.08 REMARK 500 MET A 504 115.49 -39.94 REMARK 500 VAL A 505 102.04 73.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B2B A 1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS SEQUENCE CORRESPONDS TO ISOFORM 2 OF UNP ENTRY Q06124 IN WHICH REMARK 999 RESIDUES 408-411 ARE DELETED DBREF 3MOW A 262 528 UNP Q06124 PTN11_HUMAN 262 532 SEQADV 3MOW MET A 261 UNP Q06124 INITIATING METHIONINE SEQADV 3MOW A UNP Q06124 GLN 408 VARIANT SEQADV 3MOW A UNP Q06124 ALA 409 VARIANT SEQADV 3MOW A UNP Q06124 LEU 410 VARIANT SEQADV 3MOW A UNP Q06124 LEU 411 VARIANT SEQADV 3MOW LEU A 529 UNP Q06124 EXPRESSION TAG SEQADV 3MOW GLU A 530 UNP Q06124 EXPRESSION TAG SEQADV 3MOW HIS A 531 UNP Q06124 EXPRESSION TAG SEQADV 3MOW HIS A 532 UNP Q06124 EXPRESSION TAG SEQADV 3MOW HIS A 533 UNP Q06124 EXPRESSION TAG SEQADV 3MOW HIS A 534 UNP Q06124 EXPRESSION TAG SEQADV 3MOW HIS A 535 UNP Q06124 EXPRESSION TAG SEQADV 3MOW HIS A 536 UNP Q06124 EXPRESSION TAG SEQRES 1 A 276 MET LEU TYR SER ARG LYS GLU GLY GLN ARG GLN GLU ASN SEQRES 2 A 276 LYS ASN LYS ASN ARG TYR LYS ASN ILE LEU PRO PHE ASP SEQRES 3 A 276 HIS THR ARG VAL VAL LEU HIS ASP GLY ASP PRO ASN GLU SEQRES 4 A 276 PRO VAL SER ASP TYR ILE ASN ALA ASN ILE ILE MET PRO SEQRES 5 A 276 GLU PHE GLU THR LYS CYS ASN ASN SER LYS PRO LYS LYS SEQRES 6 A 276 SER TYR ILE ALA THR GLN GLY CYS LEU GLN ASN THR VAL SEQRES 7 A 276 ASN ASP PHE TRP ARG MET VAL PHE GLN GLU ASN SER ARG SEQRES 8 A 276 VAL ILE VAL MET THR THR LYS GLU VAL GLU ARG GLY LYS SEQRES 9 A 276 SER LYS CYS VAL LYS TYR TRP PRO ASP GLU TYR ALA LEU SEQRES 10 A 276 LYS GLU TYR GLY VAL MET ARG VAL ARG ASN VAL LYS GLU SEQRES 11 A 276 SER ALA ALA HIS ASP TYR THR LEU ARG GLU LEU LYS LEU SEQRES 12 A 276 SER LYS VAL GLY GLN GLY ASN THR GLU ARG THR VAL TRP SEQRES 13 A 276 GLN TYR HIS PHE ARG THR TRP PRO ASP HIS GLY VAL PRO SEQRES 14 A 276 SER ASP PRO GLY GLY VAL LEU ASP PHE LEU GLU GLU VAL SEQRES 15 A 276 HIS HIS LYS GLN GLU SER ILE MET ASP ALA GLY PRO VAL SEQRES 16 A 276 VAL VAL HIS CYS SER ALA GLY ILE GLY ARG THR GLY THR SEQRES 17 A 276 PHE ILE VAL ILE ASP ILE LEU ILE ASP ILE ILE ARG GLU SEQRES 18 A 276 LYS GLY VAL ASP CYS ASP ILE ASP VAL PRO LYS THR ILE SEQRES 19 A 276 GLN MET VAL ARG SER GLN ARG SER GLY MET VAL GLN THR SEQRES 20 A 276 GLU ALA GLN TYR ARG PHE ILE TYR MET ALA VAL GLN HIS SEQRES 21 A 276 TYR ILE GLU THR LEU GLN ARG ARG LEU GLU HIS HIS HIS SEQRES 22 A 276 HIS HIS HIS HET B2B A 1 46 HETNAM B2B (2Z)-2-[(1R)-3-{[(1R,2S,3R,6S,7S,10S,12S,15E,17E)-18- HETNAM 2 B2B CARBOXY-16-ETHYL-3,7-DIHYDROXY-1,2,6,10,12- HETNAM 3 B2B PENTAMETHYL-5-OXOOCTADE CA-15,17-DIEN-1-YL]OXY}-1- HETNAM 4 B2B HYDROXY-3-OXOPROPYL]-3-METHYLBUT-2-ENEDIOIC ACID HETSYN B2B TAUTOMYCETIN ANALOGUE TTNB1B FORMUL 2 B2B C34 H54 O12 FORMUL 3 HOH *156(H2 O) HELIX 1 1 ARG A 265 ARG A 270 1 6 HELIX 2 2 GLN A 271 ASN A 277 5 7 HELIX 3 3 THR A 337 ASN A 349 1 13 HELIX 4 4 PRO A 432 SER A 448 1 17 HELIX 5 5 ILE A 463 LYS A 482 1 20 HELIX 6 6 ASP A 489 SER A 499 1 11 HELIX 7 7 THR A 507 GLN A 526 1 20 SHEET 1 A 8 ALA A 307 ILE A 310 0 SHEET 2 A 8 TYR A 327 GLN A 331 -1 O TYR A 327 N ILE A 310 SHEET 3 A 8 VAL A 455 CYS A 459 1 O VAL A 457 N ILE A 328 SHEET 4 A 8 VAL A 352 MET A 355 1 N VAL A 354 O VAL A 456 SHEET 5 A 8 ARG A 413 PHE A 420 1 O TYR A 418 N ILE A 353 SHEET 6 A 8 TYR A 396 LYS A 405 -1 N THR A 397 O HIS A 419 SHEET 7 A 8 MET A 383 ALA A 392 -1 N SER A 391 O LEU A 398 SHEET 8 A 8 LEU A 377 TYR A 380 -1 N TYR A 380 O MET A 383 SHEET 1 B 2 VAL A 360 GLU A 361 0 SHEET 2 B 2 LYS A 364 SER A 365 -1 O LYS A 364 N GLU A 361 SITE 1 AC1 14 HOH A 3 HOH A 126 ARG A 278 TYR A 279 SITE 2 AC1 14 LEU A 334 GLN A 335 LYS A 366 MET A 450 SITE 3 AC1 14 CYS A 459 SER A 460 ALA A 461 GLY A 464 SITE 4 AC1 14 ARG A 465 GLN A 506 CRYST1 39.542 75.977 48.376 90.00 98.86 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025290 0.000000 0.003942 0.00000 SCALE2 0.000000 0.013162 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020921 0.00000